Dr. Nathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3614 Washington Parkway
Idaho Falls, ID 83404Phone+1 208-535-8400Fax+1 208-535-8409
Summary
- Dr. Richard Nathan is an infectious disease specialist in Idaho Falls, ID and is affiliated with multiple hospitals in the area, including Mountain View Hospital, Portneuf Medical Center, and Bingham Memorial Hospital. He received his medical degree from NYIT College Of Osteopathic Medicine and has been in practice 25 years. He is experienced in bloodstream and transplant site infections.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1996 - 1998
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1995 - 1996
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1993 - 1995
- One Brooklyn Health SystemInternship, Transitional Year, 1992 - 1993
- NYIT College Of Osteopathic MedicineClass of 1992
Certifications & Licensure
- ID State License 2002 - 2025
- NY State License 1994 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- National Board of Physicians and Surgeons Infectious Disease
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
- Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections Start of enrollment: 2007 Jan 01
- An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsUpdated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensu...Matthew Greenhawt, Timothy E Dribin, Elissa M Abrams, Marcus Shaker, Derek K Chu
The Journal of Allergy and Clinical Immunology. 2023-08-01 - 7 citationsExploratory evaluation of bezlotoxumab on outcomes associated with Clostridioides difficile infection in MODIFY I/II participants with cancerOliver A. Cornely, Kathleen M. Mullane, Thomas Birch, Sabine Hazan-Steinberg, Richard Nathan
Open Forum Infectious Diseases. 2020-01-31 - 78 citationsEfficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controll...Richard Vickers, Glenn S. Tillotson, Richard Nathan, Sabine Hazan, John Pullman
The Lancet. Infectious Diseases. 2017-07-01
Press Mentions
- How Crisis Standards of Care Impacts Eastern Idaho HospitalsSeptember 16th, 2021
- Most Nursing Home Workers Unvaccinated in Idaho, New Data ShowJune 19th, 2021
- Idaho Won't Disclose Vaccination Rates in Long-Term Care FacilitiesMay 17th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Idaho Medical AssociationTrustee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: